non-st elevation acs 非st段抬高acs
The researchers determined the GRACE risk score in 681 non-ST-elevation ACS patients enrolled in a treatment trial.
研究者检查了治疗实验中681名无st段抬高的急性冠脉综合征病人的GRACE危险分数。
Conclusion Detection of plasma BNP has prognosis value in the patients with non ST segment elevation ACS.
结论血浆BNP检测对无st段抬高的ACS患者预后有较好的判断价值。
Objective There have been many controversies on the value of percutaneous coronary intervention (PCI) in patients of non-ST-segment elevation ACS.
目的： 长期以来，介入治疗在非ST段抬高的急性冠脉综合症（ACS）患者的价值方面，意见不一。
应用推荐